2012 update of the 2008 American college of rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

Jasvinder A. Singh, Daniel E. Furst, Aseem Bharat, Jeffrey R. Curtis, Arthur F. Kavanaugh, Joel M. Kremer, Larry W. Moreland, James O'Dell, Kevin L. Winthrop, Timothy Beukelman, S. Louis Bridges, W. Winn Chatham, Harold E. Paulus, Maria Suarez-Almazor, Claire Bombardier, Maxime Dougados, Dinesh Khanna, Charles M. King, Amye L. Leong, Eric L. MattesonJohn T. Schousboe, Eileen Moynihan, Karen S. Kolba, Archana Jain, Elizabeth R. Volkmann, Harsh Agrawal, Sangmee Bae, Amy S. Mudano, Nivedita M. Patkar, Kenneth G. Saag

Research output: Contribution to journalArticle

1143 Scopus citations
Original languageEnglish (US)
Pages (from-to)625-639
Number of pages15
JournalArthritis Care and Research
Volume64
Issue number5
DOIs
StatePublished - May 2012

ASJC Scopus subject areas

  • Rheumatology

Cite this

Singh, J. A., Furst, D. E., Bharat, A., Curtis, J. R., Kavanaugh, A. F., Kremer, J. M., Moreland, L. W., O'Dell, J., Winthrop, K. L., Beukelman, T., Bridges, S. L., Chatham, W. W., Paulus, H. E., Suarez-Almazor, M., Bombardier, C., Dougados, M., Khanna, D., King, C. M., Leong, A. L., ... Saag, K. G. (2012). 2012 update of the 2008 American college of rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care and Research, 64(5), 625-639. https://doi.org/10.1002/acr.21641